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INTRODUCTION 
  
Brain tumors are the most common neoplasms in children. They represent 
second most common pediatric malignancy overall, following leukemia. After 1 
year of age, most of the pediatric brain tumors occur in in the posterior fossa. They 
include medulloblastomas, juvenile pilocytic astrocytomas, ependymomas, 
haemangioblastomas, germ cell tumors of pineal gland and brain stem gliomas. 
Children with posterior fossa brain tumors usually present with symptoms of 
increased intracranial pressure, gait disturbances, and/or cranial nerve deficits. The 
symptoms and signs depend upon the size, type and location of the tumor.  
Computed tomography (CT) and magnetic resonance imaging (MRI) are 
critical in the work-up and follow-up of these patients. Treatment options depend 
upon the patient‟s age and the disease extent. Surgical resection with radiation 
and/or chemotherapy is the usual treatment option. These tumors frequently 
metastasize through cerebrospinal fluid (CSF) and produce “drop metastasis” along 
craniospinal axis. Hence it is necessary to irradiate the entire craniospinal axis if it 
is present. In addition, posterior fossa has to be treated with booster dose 
radiotherapy.   
 
 
  
Medulloblastoma is a malignant tumor which occurs most frequently in 
children but may also affect adults. It is the second most common pediatric brain 
tumor overall, following astrocytoma. But it is the most common posterior fossa 
tumor in the pediatric population which contributes up to 40% of cases. Children 
with medulloblastomas often present clinically with rapid onset of symptoms over 
the course of weeks or a few months. This is due to the rapid growth and malignant 
features of the neoplasm. The most common symptoms include headache, nausea 
and vomiting due to fourth ventricular obstruction and the resulting hydrocephalus. 
Truncal ataxia and papilledema are common clinical signs. Tumor cell seeding of 
the cerebral spinal fluid (CSF) is seen in nearly one third of the cases. MRI brain 
with gadolinium contrast is the investigation of choice. Screening of entire neural 
axis is included in the imaging study. The primary treatment of medulloblastoma is 
surgical excision of tumor which should be followed by adjuvant therapy. The 
adjuvant therapy depends on the child‟s age, extent of resection and 
presence/absence of CSF dissemination of tumor cells. 
  
 
Juvenile pilocytic astrocytomas are low grade neoplasms belonging to WHO 
grade I. They are the most common subtype of pediatric gliomas and contribute 
85% of all cerebellar astrocytomas. They represent approximately one-third of 
posterior fossa tumors in children, second in incidence only to medulloblastoma.  
Patients with cerebellar pilocytic astrocytoma typically present with a gradual 
onset of symptoms due to its slow growth. They involve midline vermis or 
cerebellar hemisphere laterally. They are usually well-circumscribed and have a 
large cystic component with a mural nodule. Surgical resection of cerebellar 
astrocytomas is the primary modality of treatment. Surgery is curative if resected 
completely. Repeat surgical excision is the treatment for recurrences or regrowth 
after subtotal resection. Radiation and/or chemotherapy are reserved for rare 
instances which are not amenable to surgical resection. 
 
  
Ependymomas arise from ependymal cells which line the ventricles. They 
also arise from spinal cord from the ependymal lining of central canal. 
Supratentorial (lateral ventricle) and spinal ependymoma are common in adults. 
Infratentorial ependymomas are more common in children where they arise from 
ependymal cells of floor of the IV ventricle. Ependymomas rank three among the 
posterior fossa tumors in pediatrics after medulloblastoma and cerebellar pilocytic 
astrocytoma. They occur along the floor (more common) or roof of the fourth 
ventricle. Ependymomas of IV ventricle are usually WHO grade II. CSF 
dissemination is seen in approximately 12% of cases. Children with ependymoma 
present with features of increased intracranial pressure (ICP) due to fourth 
ventricular obstruction and hydrocephalus. They are usually mixed intense lesion 
on imaging with propensity for calcification and cystic degeneration. Complete 
surgical excision is the treatment of choice but it is difficulty because of its 
adherence to adjacent vital structures. Adjuvant therapy is based on age of the 
child and presence of CSF dissemination. 
 
 
Brainstem gliomas are fourth in incidence in terms of pediatric posterior 
fossa tumors representing approximately 15% of total. Diffuse intrinsic pontine 
glioma (DIPG) is the most common and most aggressive type of brainstem glioma. 
Histologically fibrillary astrocytomas (WHO grade II) are common but they can 
progress to anaplastic or even glioblastoma multiforme. Children with brainstem 
gliomas have rapid onset of cranial nerve deficits, long tract signs and ataxia. Due 
to its location, surgery is not the primary treatment. Surgery is reserved for focal, 
exophytic lesion with cystic component. Radiotherapy and chemotherapy are the 
mainstays of the treatment of brain stem gliomas.   
 
.   
 AIM OF THE STUDY 
 
1. To study the distribution of various types of posterior fossa tumors in children 
of age group 6 months to 12 years during my study period. 
2. To study the frequency of symptoms of posterior fossa tumors in children. 
3. To study the various imaging features of posterior fossa tumors seen in 
children. 
4. To analyze the need of preoperative shunting in patients with obstructive 
hydrocephalus. 
5. To study the prognosis of different types of tumors after definitive surgical 
treatment. 
 
This is a descriptive study on the incidence, symptoms and signs, imaging 
features, treatment and prognosis of posterior fossa tumors in pediatric population. 
This work has been compared with related works available in the literature. The 
period of this study is from November 2011 to November 2013. 
 REVIEW OF LITERATURE 
 
There are many studies conducted by pioneering authors on the posterior 
fossa children in pediatric population. Various papers have been published at 
various points of time across the world, most of these from premier institutes in 
neurosciences. 
 
HISTORY 
Development of posterior fossa surgery was one of the hallmarks of Harvey 
Cushing contribution to pediatric branch of neurosurgery
1
. During the pre-Cushing 
era, posterior fossa lesions were considered inoperable and bony decompression 
alone was done without attempting tumor removal. The evolution of Cushing‟s 
surgical expertise from subtotal excision to total excision of vascular fourth 
ventricular tumors reflects the importance of fine neurosurgical techniques. This 
was proven by dramatic decrease in his operative mortality rate. In 1931, Cushing 
published the first series of posterior fossa astrocytoma in pediatric population 
which is one of the most important contributions to pediatric neurosurgery. It 
appeared in Surgery, Gynecology and Obstetrics in 1931. This was entitled 
“Experiences with cerebellar astrocytomas: a critical review of 76 cases. In another 
study, Cushing treated 109 boys and 64 girls who were less than 18 years of age 
with posterior fossa tumors. The most common presenting symptoms included 
unsteadiness, progressive visual loss, projectile vomiting, headache, double vision, 
motor deficits and sensory deficits and opisthotonic convulsions (“cerebellar fits”). 
His examination findings included fundus examination, visual acuity and field, 
tenderness in suboccipital region, hypotonia and “crack pot resonance of the skull.”  
 
DEMOGRAPHY 
Naseem Ahmed et al
2
 from Karachi reviewed 81 cases in his study of which 
58 were male and 23 were female (ratio 2.5:1). He divided the patients into 3 
groups according to age (0 - 4, 5 - 9, 10 -14 years) mean age being 8.8 years The 
maximum number of cases (43 cases - 33 males and 10 females) were observed in 
the age group 5 - 9 years. 25 cases (17 males and 8 females) were present in the 
age group 10 - 14 years. The least number of cases (13 cases - 8 males and 5 
females) were present in the age group 0 - 4 years. The pathology of various 
tumors he found in his study population included astrocytoma (28 cases, 34.6%), 
medulloblastoma (40 cases, 49.4%), ependymoma (8 cases, 10%) and others (5 
cases, 6.2%). The study reflects a developing country scenario, with a strong male 
predisposition and a late presentation with a peak in the 5 - 9 year age group.  
Tai-Tong Wong, M.D et al
3
 of Taiwan conducted a trial of single 
institutional series of 986 pediatric patients with primary brain tumors from 1975 
to 2004. Of these patients, they were able to identify the histological diagnosis in 
886 patients. Of these 886 patients, the most common tumors encountered by him 
were astrocytoma (31.1%), germ cell tumor (14.0%), medulloblastoma (13.3%), 
craniopharyngioma (8.3%), and ependymal tumor (5.8%). In addition to 91 cases 
of pineal tumors, there were 575 supratentorial tumors and 405 infratentorial 
tumors.  6 patients had both supra- and infratentorial tumors. The mean age was 
7.8 years. Except for the age group between 2 and 8 years, males were 
predominantly affected in all other age groups. In the posterior fossa, most tumors 
were mainly medulloblastomas, astrocytomas, brain stem gliomas, ependymoma 
and atypical rhabdoid tumors. In cerebellar vermis, 65.3% tumors were 
medulloblastomas. In cerebellar hemisphere, 63.5% were astrocytomas. Among 
120 patients of primary brain stem tumors, only 46 (38.3%) had been operated and 
the histology was known. The predominant histologic diagnosis was astrocytomas. 
  
PRESENTATION 
Anthony. J. Raimondi et al
4
 studied the incidence, symptoms and 
hydrocephalus management associated with posterior fossa tumors. In his study, 
156 children with posterior fossa tumors and 21 children with pineal tumors were 
analyzed. Of 117 children with cerebellar fourth ventricle tumor, 110 (94.01%) had 
obstructive hydrocephalus, whereas 11 (32.35%) of 34 patients with brain-stem 
tumors had hydrocephalus and all children 21 (100%) with pineal tumors presented 
with obstructive hydrocephalus. The symptoms and signs of these patients were 
grouped into hydrocephalic (headache, vomiting, lethargy, increased head 
circumference, papilledema, 6
th
 nerve palsy) and non-hydrocephalic (unsteadiness, 
head tilt, weakness, seizures, cerebellar signs, lower CN palsy). Of the total 143 
(91.67% of total) patients with hydrocephalus, shunt was inserted before 
craniotomy in 123 children before tumor removal. Upward herniation and CSF 
seeding of peritoneum through the shunt tube are contraindications to shunt 
insertion before craniotomy.  
 
 Leland Albright et al
5
 reviewed 86 patients with posterior fossa tumors with 
secondary hydrocephalus. In this study 47 children had not been treated with any 
CSF diversion procedures like external ventricular drainage (EVD) or 
ventriculoperitoneal (VP) shunt. 27 patients were treated with VP shunt. 12 
patients were treated with EVD during posterior fossa surgery. Patients treated 
with VP shunt before tumor surgery had favorable outcome compared to non-
shunted patients. The peri-operative mortality was also less in the former (3.7 %) 
group compared to latter (12.8 %).  Complication of placement of a shunt before 
posterior fossa surgery included problems related to shunt placement like shunt 
infection, dysfunction, etc and the chance of seeding of peritoneum with tumor 
cells.  
 
 
TIME OF RADIOLOGICAL DIAGNOSIS 
Lutz Dörner et al
6
 analyzed 50 children with posterior fossa tumors 
retrospectively. He analyzed the time interval between the onset of first symptom 
and radiological diagnosis. The mean age at time of diagnosis was 98 months. 
Clinical symptoms of the patients in this series included headache, nausea, 
vomiting, decreased level of consciousness, unsteadiness or cranial nerve deficit. 
The mean time interval from the onset of first symptom to radiological diagnosis 
was 142 days. The mean time interval for Grade I and II tumors (n=19) was 238 
days. The mean time interval for Grade III and IV (n=31) was 117 days. Inspite of 
the fact that posterior fossa tumors are among the most significant solid tumors in 
childhood age, they are sometimes misdiagnosed for more common differential 
diagnoses. Patients in this study have been misdiagnosed and treatment was given 
for gastroenteritis (n=9), appendicitis (n=1), behavioral problems (n=4), cervical 
spine pathologies (n=9) and different ophthalmologic diagnosis (n=5). The 
symptoms of obstructive hydrocephalus led to early the diagnosis. 
 Roger J. Packer, MD
7
 et al studied the distribution and characteristics of 
various pediatric brain tumors. Infratentorial tumors may present with focal 
neurologic deficits, but they frequently present to the clinical attention because of 
obstruction of cerebrospinal fluid with associated hydrocephalus. The classical 
triad associated with increased intracranial pressure of morning headaches, nausea, 
and vomiting, may occur, but nonspecific headaches are more frequent. In infants, 
cerebrospinal fluid obstruction with ballooning of the third ventricle and the 
resultant tectal compression causes paresis of up gaze “the sun set sign”. Because 
of the speed and availability of CT, it is often the first imaging technique for 
children with posterior fossa tumor symptoms. CT will detect 95% or more of 
brain tumors. Because of the superior spatial resolution of MRI, it is essential in 
the diagnosis of brain tumors. In attempts to avoid postoperative artifacts, an MRI 
of the entire neurospinal axis often is undertaken before surgery in patients who 
have presumed malignant tumors.  
 
 
 
 
NEURORADIOLOGICAL ASSESSMENT 
Jeffrey E. Arle, M.D
8
 et al obtained radiological data obtained via MRI in 33 
children with posterior fossa tumor. Eleven imaging characteristics were noted for 
each patient. These included:  
1. Midline or hemispheric location 
2. Proton density 
3. Tumor intensity on T2 weighted image (hypo, iso or hyperintense)  
4. Cystic 
5. Solid 
6. Contrast enhancement 
7. Edema 
8. Flow void 
9. Hemorrhage within the tumor 
10. Focal versus diffuse involvement  
11. Obstructive hydrocephalus 
The medulloblastomas and ependymomas were the most confusing tumors 
whereas astrocytomas had a 100 % of positive predictive value. Ependymomas had 
the lowest positive predictive value (0.57). When using three spectroscopy ratios, 
almost 60% of the cases could be predicted. Addition of patient age, sex and size 
of the tumor to the spectroscopy data could achieve almost as much predictive 
value of 87.8%. This study provides the value of an accurate preoperative 
histological diagnosis in pediatric posterior fossa tumors. A preoperative 
neuroimaging data with good diagnostic accuracy can replace the intraoperative 
frozen section biopsy in guiding surgery. Another advantage of knowing the 
histological type of tumor from diagnostic studies is that pre-operative adjuvant 
chemotherapy can be considered based on the imaging diagnosis. Furthermore, 
time-consuming spinal staging MR studies in search of drop metastases may be 
avoided for patients with typical cerebellar astrocytomas and they may be 
selectively obtained for ependymoma and medulloblastoma preoperatively when 
the tests are most accurate. 
 
PILOCYTIC ASTROCYTOMA 
Pilocytic astrocytoma accounts for 6% of all brain tumors in humans but in 
children these tumors constitute approximately 15%. The properties of these 
tumors were location within the cerebellum, commonly cystic, presentation at 
younger age group and most importantly these tumors have a very good prognosis. 
These cystic lesions of the cerebellum were previously referred to as "gliomatous 
cysts".  In 1932, Bergstrand found that many of the tumor cells were uni- or bipolar 
spongioblasts. These were reminiscent of cells found during the late embryonal 
development. Hence the term "gliocytoma embryonale" was proposed by him for 
these tumors. Bucy and Gustafson were not favouring this theory and stated that 
the cerebellar astrocytoma is a neoplastic entity. In addition they found typical 
hyaline bodies in these lesions and named these bodies as “Rosenthal fibers”. In 
1977 Russell and Rubinstein introduced the term "juvenile pilocytic astrocytoma”. 
The name "pilocytic astrocytoma" was given to these tumors by the WHO 
classification system of CNS tumors. Mostly the cerebellar pilocytic astrocytomas 
occur in the age group 5 - 10 years, with equal predilection among males and 
females
9
. Presenting symptoms and signs can be grouped into: symptoms caused 
by increased intracranial pressure and symptoms due to local brain dysfunction at 
the site of the tumor (cerebellar and brain stem features). In infants the increased 
head size may be the first symptom. The raised intracranial pressure may cause 
widening of sutures with a bulging fontanelle. The child will become irritable, 
lethargic and decreased cry and activities at later period if not treated. Most 
commonly they are located in the cerebellar vermis, extending asymmetrically to 
one or both cerebellar hemispheres. Sometimes they are confined to one cerebellar 
hemisphere. Mostly these tumors consist of a single large cyst with a mural tumor 
nodule.  
 
Histologically they have a biphasic pattern. These tumors show loose areas 
of microcysts and stellate or protoplasmic-type astrocytes with more compact areas 
containing the typical elongated piloid astrocytes with cytoplasmatic fibrillation 
10
. 
In the more compact areas, Rosenthal fibers are almost always present. Mitoses 
and necrosis are rare presenting in less than 20%. The treatment of first choice is 
surgical resection and the aim of surgery should be total resection. If the cyst wall 
shows contrast-enhancement on CT or MRI, it is very likely to contain tumor cells 
and should be resected
11
. In tumors showing cyst which is not enhanced, only the 
resection of the mural nodule alone will be sufficient. Intraoperatively when the 
inside of the cyst is smooth, the presence of tumor cells in the cyst wall is very 
unlikely. Conversely, when the cyst-wall is thick and shows a gelatinous 
appearance, it indicates the infiltration of cyst wall with tumor cells and those cyst 
walls should be resected. Survival after complete total tumor removal is excellent. 
The role of radiation therapy is very limited in the treatment of cerebellar pilocytic 
astrocytomas except when there is a recurring tumor at an inoperable site. 
 
MEDULLOBLASTOMA 
Medulloblastoma once thought to be a fatal tumor may be apparently cured 
by complete surgical resection as far as possible with adequate irradiation of the 
posterior fossa and entire craniospinal axis. Dattatraya Muzumdar and Enrique CG 
Ventureyra
12 
reviewed many articles published of posterior fossa tumors about 
posterior fossa tumor. In his review article it is stated that medulloblastoma occurs 
predominantly in males (ratio 1.4:1) and more commonly in the age group 5 to 7 
years. It occurs in association with Gorlin‟s syndrome and Turcot‟s syndrome. 
Seeding of tumor cells in the craniospinal axis is found in 11 – 43% of patients and 
is one of the most important predictors of outcome. The WHO classification of 
medulloblastoma is based on light microscopy and immunohistochemical findings. 
It comprises classical medulloblastoma, the large cell anaplastic variant, 
desmoplastic variant, medullomyoblastoma variant and melanotic variant
13
. The 
nodular type has a better prognosis when compared with classical 
medulloblastoma. The most malignant variant is the large cell anaplastic 
medulloblastoma which accounts for 4% of cases. Drop metastases through CSF 
occur in up to 40% of patients. These drop metastases are more commonly seen in 
lumbosacral and thoracic levels. They are best seen on post-contrast T1-weighted 
images in which they appear as “icing sugar appearance”. Hence it is necessary to 
have MRI of the spine before treatment for staging the disease. The extraneural 
metastasis of medulloblastoma occurs in bone and bone marrow.  
 
The aim of the surgery should be aimed at total removal of the tumor 
without endangering life or causing significant morbidity. The current standard 
adjuvant treatment for average risk medulloblastoma includes postoperative 
craniospinal irradiation with 23.4 Gy and posterior fossa booster with 54 Gy 
followed by 12 months of chemotherapy. Irradiation in young children causes 
severe neurological morbidity and cognitive impairment. Hence irradiation is 
contraindicated in children younger than the age of 3 years. Chemotherapy 
includes cisplatin, vincristine, lomustine, cyclophosphamide and oral etoposide 
which are used alone or in combination. 
 
Treatment regimen of medulloblastoma according to risk stratification 
 
 
 
 
 
EPENDYMOMA 
 Fulya Yaman Agaoglu, MD
14
 et al studied demographic data and treatment 
results of 40 patients below 16 years of age with ependymoma. There were 
22 males and 18 females aged from 3 months to 15 years old, with a median age of 
5.5 years. These tumors represent for 5–10% of all brain tumors in the pediatric 
age group ranking third in the frequency following astrocytoma and 
medulloblastoma. The origin is from ependymal cells from the floor of fourth 
ventricle. The risk of meningeal dissemination in ependymomas is about 2–30%23.  
CT and MRI with gadolinium are the main modality of investigating ependymoma. 
MRI should include entire craniospinal screening to detect “drop metastasis” 
preoperatively. Post treatment MRI should be taken 6 weeks following surgery to 
eliminate post-operative artifacts. 
 
Fourth ventricular ependymomas can be preoperatively classified as lateral 
type or mid floor type tumors. This correlates well with extent of resection. 
Lateral-type tumors have significantly increased risk of residual tumor compared 
to mid floor type tumors
15
. Treatment should be aimed at complete tumor resection 
without compromising neurological function. Total tumor resection was performed 
in 20 patients (50%), subtotal in 18 patients (45%) and biopsy only in 2 patients 
(5%). Histologic diagnosis was 18 Grade I ependymomas (Grade 1- 45%) and 22 
anaplastic ependymomas (Grade 3 - 55%). Postoperative treatment consisted of 
regional radiotherapy alone in patients with ependymoma without CSF seeding of 
tumor cells (n=8). Regional and craniospinal irradiation (n=9) in patients were 
given for patients with CSF seeding. Regional and craniospinal irradiation with 
chemotherapy in patients with anaplastic ependymoma (n=14). Chemotherapy 
alone was given in one patient (less than 3 years of age). The standard technique 
for posterior fossa irradiation was followed in this study which is craniospinal 
irradiation of 36 Gy (range 30 – 40 Gy) and booster to the primary site of 54 Gy 
(range 46 - 60 Gy). These patients received adjuvant therapy of radiotherapy (boost 
and craniospinal irradiation) and concomitant infusion of cisplatin (as 
radiosensitizer) followed by „„VCPCU‟‟ (vincristine, cyclophosphamide, 
procarbazine, lomustine) administered every 4 weeks for eight course. The 
majority of complete responders were patients who had total tumor removal. The 
completeness of the surgical resection is the most significant factor that has the 
greatest impact on the outcome of children with ependymoma.  
 
BRAIN STEM GLIOMA 
 Albright et al
16 
published a manuscript that changed the course for the 
treatment of children with diffuse intrinsic pontine gliomas (DIPGs). The point of 
the paper was that if a child presented with a short clinical history, had cranial 
nerve findings and long-tract signs and had the typical MR imaging appearance of 
a diffuse pontine glioma, there was no difference in treatment or outcome in that 
patient population based on biopsy findings. Children with brain stem gliomas 
have poor prognosis. Mostly they die within 2 years of diagnosis. Intrinsic brain 
stem tumors have traditionally been treated with non-operative measures like 
irradiation and adjuvant chemotherapy. Despite this dismal prognosis, that there 
may be at least a few cases of brain stem gliomas that were both surgically 
resectable and low-grade. 
 
Fred Epstein, M.D et al
17 
analyzed surgical indication in 34 children with 
brain stem gliomas. Three tumor subgroups had been described in his study: Focal, 
Diffuse and Cervicomedullary based on MRI findings. A focal tumor is a 
circumscribed mass less than 2 cm in diameter without edema. A diffuse tumor has 
a large hypodense component with or without a "focal" component. 
Cervicomedullary neoplasms involve the lower two-thirds of the medulla and the 
rostral segments of the spinal cord. In his series (n=34), 22 were diffuse, 4 focal, 
and 8 cervicomedullary types. All patients (22) with diffuse neoplasms had rapidly 
progressive signs and symptoms typical of a brain-stem glioma like multiple 
cranial nerve dysfunction associated with spasticity in the lower extremities. All of 
these patients were severely disabled at the time of surgery. 3 of 4 patients with a 
focal tumor had an atypical clinical presentation with insidious onset of one cranial 
nerve palsy. They had remission lasting from 12 to 24 months but significant 
neurological deterioration gradually evolved after 2 years and 2 patients were 
severely disabled at the time of surgery. 8 patients with cervicomedullary tumors 
had lower cranial nerve dysfunction associated with symptoms mimicking upper 
cervical cord lesion like hemiparesis, quadriparesis and spasticity. The clinical 
course was consistently protracted and significant disability did not occur until 1 to 
3 years follow up after radiotherapy. With brain stem evoked potential monitoring 
these tumors were approached through floor of fourth ventricle or retromastoid 
approach. The dissection was limited within the tumor only aiming at radical tumor 
excision without neurological deterioration. All diffuse type tumors (22) had 
malignant grade  (Grade 3 or 4) and they respond poorly for any form of treatment. 
3 out of 4 focal tumors had benign histology (Grade 1 or 2). All cervicomedullary 
tumors (8) were benign astrocytomas (Grade 1 or 2). Both focal and 
cervicomedullary type tumor responded well to the surgery and they had excellent 
neurological recovery.  
 
   In 1980, Hoffman et al
18
 reported that children with exophytic brainstem 
gliomas survived substantially longer than children with the usual intrinsic brain 
stem tumors. A. Leland Albright, M.D
16
 et al published a series of 84 children with 
brainstem gliomas and found that the prognosis of children with brain-stem 
gliomas is significantly worse in children whose first symptoms include one or 
more cranial nerve palsy. Poor prognosis was also seen in patients whose CT scans 
show a hypodense or diffuse tumor and in those whose tumor biopsy material 
contains mitoses or features of high grade tumor. Conversely, the prognosis is 
much better for patients in whom the above features are absent, particularly if the 
biopsy specimen contains calcification or Rosenthal fibers. 
 
COMPLICATIONS 
 Jay Riva Cambrin. M.D. M.Sc. et al
19
 studied the frequency of post resection 
hydrocephalus in children with posterior fossa tumors. Approximately 30% of 
pediatric patients with posterior fossa tumors exhibit hydrocephalus after tumor 
resection. Recently many literatures suggested that prophylactic ETV diminishes 
the risk of postoperative hydrocephalus. However treating all children with 
posterior fossa tumors this way potentially exposes approximately 70% of patients 
to an unnecessary procedure that can have significant risks
20
. In this study 
individual variables like age, degree of hydrocephalus and intracerebral metastases 
in combination with novel predictors such as papilledema and preoperative 
estimations of specific tumor pathological findings were validated. 
    
Canadian preoperative prediction rule           The CPPRH’s predicted                  
for Hydrocephalus(CPPRH)
19
      probabilities of Post-resection  
                                                                 Hydrocephalus at 6 months
19
                                              
 
 
 
 
 
 
 
 
 
 
 
 
 
Steinbok et al
21
 retrospectively analyzed children with posterior fossa tumors 
treated surgically who had CSF leak and pseudomeningocele formation. 
Craniotomy has proved to have some protective effect compared to craniectomy. 
The replaced bone flap limit the stretching of the sutured dural membrane in case 
of postoperative swelling of the cerebellum or/and fluid accumulation within the 
posterior cranial fossa. 
Predictor  Score  
 Age < 2 year 
Presence of papilledema 
Moderate/ severe hydrocephalus 
Cerebral metastasis 
Pre op provisional diagnosis 
       Medulloblastoma 
       Ependymoma 
Dorsally exophytic brain  stem 
glioma 
3 
1 
2 
3 
 
1 
1 
1 
Total  10 
CPPRH 
SCORE 
PROBABILITY 
0 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
0.071 
0.118 
0.191 
0.293 
0.422 
0.562 
0.693 
0.799 
0.875 
0.925 
0.956 
 Luigi Ferrante, M.D et al
22
 reported three cases of mutism after posterior 
fossa surgery. Generally speech disturbances occur frequently after surgical 
removal of posterior cranial fossa tumors especially when the surgery involves a 
resection of a cerebellar lobe (particularly the left) and part of the vermis. These 
are generally termed as “dysarthria”. An unusual finding after posterior fossa 
surgery is mutism (complete absence of speech in a conscious patient). In this 
study, mutism arose 18 to 72 hours after the operation (mean - 41.5). Extensive 
destruction of the median and paramedian cerebellar substance involving the deep 
nuclei (dentate nuclei) is probably the most important anatomical substrate of 
mutism. 
 MATERIALS AND METHODS 
 
STUDY PATTERN 
 This study was conducted at Institute of Neurology, Madras Medical College 
& Rajiv Gandhi Govt. General Hospital from November 2011 to November 2013 
after obtaining proper clearance from ethical committee. The study included 52 
patients of age more than 6 months and less than 12 years with posterior fossa 
tumors.  
 
INCLUSION CRITERIA 
 All patients admitted in pediatric neurosurgical ward with age more than 6 
months and less than 12 years having posterior fossa tumors were included in this 
study. 
 
 
 
 
 
 
 EXCLUSION CRITERIA 
The following patients were excluded from the study, 
 
1. Children less than 6 month of age 
2. Children with posterior fossa mass but the imaging features and/or 
histological features suggestive of  inflammatory pathology 
3. Children with posterior fossa cystic mass but the imaging and/or 
histological features suggestive of arachnoid cyst 
4. Children who underwent any form of surgical intervention at some other 
institutions 
5. Children with lesions in both supra and infratentorial compartments 
6. Children who died before commencing any form of intervention 
7. Children who died before MRI was taken 
8. Children for whom their parents not willing for any form of intervention 
9. Patients who were discharged from the hospital against medical advice 
 
On admission, patient‟s clinical profile such as age, sex, presenting 
symptoms and signs were recorded. All children with features of increased ICP 
and/or decreased alertness were subjected to urgent CT brain to rule out 
obstructive hydrocephalus.  
Patients having obstructive hydrocephalus and features of raised ICP and/or 
decreased alertness were treated with emergency VP shunt. If the children with 
hydrocephalus did not have features of raised ICP or decreased alertness were 
observed cautiously. This subgroup of children was subjected to urgent MRI study 
with craniospinal screening with a neurosurgical resident accompanying the child 
during study. They were posted in next elective theatre list if possible.  
 
If the admission CT scan show mild obstructive hydrocephalus and children 
were relatively well preserved, they are subjected to elective MRI study. They 
were treated with elective posterior fossa tumor surgery without prior shunting.  
The intraoperative EVD or VP shunt during posterior fossa surgery was 
determined by alertness of the child on the day of elective surgery and intra 
operative factors (possibility of post-operative intraventricular (IVH) , tumor not 
completely resected, tense posterior fossa). 
Almost all children (except few intrinsic brain stem lesions) were treated 
surgically. Almost all of the surgically treated patients were positioned prone 
(except tumor epicenter in CP angle) on pediatric horse-shoe frame, their head 
plastered to the frame. Pediatric May field pin fixator was not used for fear of skull 
fracture and extra-axial hematomas. Midline suboccipital craniectomy (craniotomy 
was not done) was done for all midline vermian tumors and midline dorsally 
exophytic brain stem tumors. If major proportion of the tumor was present laterally 
over cerebellar hemisphere or cerebellopontine angle, either paramedian 
suboccipital craniectomy or retromastoid suboccipital craniectomy was done 
respectively. If retromastoid suboccipital craniectomy was the approach, then the 
child was positioned lateral with mastoid at the highest point. Most of the midline 
vermian and lateral hemispheric tumors (> 50%) were resected radically (either 
near total or total excision). Brain stem lesions were treated either with biopsy 
alone or partial excision.  
Postoperative EVD or shunting was based on patient‟s condition during the 
postoperative period. The first follow up CT brain was taken on the first 
postoperative day. If CT scan showed fresh IVH and/or hydrocephalus (moderate 
to severe) with residual tumor they were subjected to CSF diversion procedure 
irrespective of clinical condition. If the children had CSF leak from the wound 
and/or bulging pseudomeningocele in the presence of hydrocephalus, they are also 
subjected to shunting after the failure of conservative measures. 
Almost all the patients with posterior fossa tumors (except pilocytic 
astrocytoma) were subjected to adjuvant therapy. Children less than 3 years of age 
were treated with chemotherapy till they reached 3 years of age. After 3 years of 
age, they were subjected to radiotherapy which included 54 Gy given in 
fractionated doses to posterior fossa along with 23.4 Gy to entire craniospinal axis 
in fractionation. 
 The following factors were studied and analyzed descriptively and 
statistically, whether they could prove as positive predictive factors 
1. Demographic data 
     Age 
     Sex 
2. Presentation  
    ICP features (headache, vomiting) 
    Cranial nerve deficit 
    Others (torticollis, recurrent lower respiratory tract infection 
    (LRI), failure to thrive, weakness, unsteadiness) 
3. Imaging characteristics 
      Solid 
      Cystic 
      Mixed 
      Midline  
      Midline with lateral extension 
      Presence of hydrocephalus 
4. Intervention  
      Preoperative shunting 
      Intra operative shunting/ EVD 
      Post-operative shunting/ EVD 
5. Extent of tumor resection 
     Partial excision 
     Subtotal excision 
     Near total excision 
     Total excision 
6. Complications of treatment 
     CSF leak 
     Pseudomeningocele 
     Lower cranial nerve palsy 
     Aspiration pneumonitis 
     Death  
 
 
 
 
RESULTS 
 Total number of patients (age less than 12) admitted in the pediatric ward in 
the study period was 588. Of which 52 (8%) patients had posterior fossa tumors. 
The rest of the patients (92%) had other diagnosis like congenital or infective 
hydrocephalus, trauma, other tumors and CV junction anomaly). 
 
CHART – 1 
 
 
  
All the patients with posterior fossa tumors were grouped into three groups 
based on age  1. Group 1 – 6 months to 4 years 
   2. Group 2 – 5 years to 8 years 
   3. Group 3 – 9 years to 12 years. 
The incidence of posterior fossa tumors in each group is noted and plotted in the 
graph as follows:    
CHART - 2 
        
       
 In this study, posterior fossa tumors are more common in group 1 and     
group 2. This implies that these tumors are more common below 9 years of age. 
 
Similarly the sex distribution of posterior fossa tumors in the study 
population was noted. The distribution is almost equal among both sexes (male – 
25, female – 27). However the distribution of different types of posterior fossa 
tumors was not equal among both the sexes which are described subsequently. 
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a) Distribution of different types of posterior fossa tumors among different 
age groups and sex in the study population 
 
The distribution of various types of posterior fossa tumors among 
various age groups in the study population was analyzed. 
 
 
TABLE - 1 
  HISTOLOGY 
  PILOCYTIC 
ASTROCYTOMA 
EPENDYMOMA MEDULLOB
LASTOMA 
DIFFUSE 
ASTROCYTOMA 
OTHERS HPE 
NOT 
DONE 
TOTAL 
 
 
AGE 
6 MONTHS -  
4 YEARS 
4 9 4 1 2 1 21 
5 - 8YEARS 9 2 6 1 1 3 22 
9 - 12 YEARS 4 1 3 0 0 1 9 
 Total 17 12 13 2 3 5 52 
OTHERS – Haemangioblastoma, germinoma, chloroma 
HPE NOT DONE – Histology was not done because these tumors are intrinsic   
     brain stem tumors 
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OTHERS – Haemangioblastoma, germinoma, chloroma 
HPE NOT DONE – Histology was not done because these tumors are intrinsic 
                       brain stem tumors 
 
 From the above chart - 4 and table - 1, it is clear that pilocytic astrocytoma 
and medulloblastoma were common in the age group 5 to 8 years compared to 
other groups. And ependymoma is common in the age group 6 months to 4 years. 
TABLE - 2  
 HISTOLOGY 
 PILOCYTIC 
ASTROCYTOMA 
EPENDYMOMA MEDULLOBLAST
OMA 
DIFFUSE 
ASTROCYTOMA 
OTHERS HPE 
NOT 
DONE 
TOTAL 
MALE 7 6 8 2 1 1 25 
FEMALE 10 6 5 0 2 4 27 
TOTAL 17 12 13 2 3 5 52 
OTHERS – Haemangioblastoma, germinoma, chloroma 
HPE NOT DONE – Histology was not done because these tumors are intrinsic   
     brain stem tumors. 
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               OTHERS – Haemangioblastoma, germinoma, chloroma 
                  HPE NOT DONE – Histology was not done because these tumors are  
                                               intrinsic brain stem tumors 
 
 
From the above chart - 5 and table -  2, ependymomas were equally 
distributed among males and females, medulloblastomas were more common in 
males (Male to Female Ratio is 1.6: 1) and pilocytic astrocytoma is more common 
in females (Female to Male Ratio is 1.4: 1). 
 
 
 
b) Distribution of various clinical presentations of posterior fossa tumors in 
the study population. 
 
The presenting symptoms of posterior fossa tumors in the study population 
were analyzed. 
 
 
TABLE - 3 
SYMPTOMS 
FREQUENCY 
( n= 52) 
PERCENTAGE 
HEADACHE 25 48.1 
VOMITING 38 73.1 
CRANIAL NERVE DEFICIT 25 48.1 
OTHERS 27 51.9 
             OTHERS – Torticollis, failure to thrive, obtundation, recurrent  
          respiratory tract infection, unsteadiness and weakness 
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             OTHERS – Torticollis, failure to thrive, obtundation, recurrent  
          respiratory tract infection, weakness, unsteadiness 
 
 
Most of the posterior fossa tumors among the study population presented with 
symptoms of increased intracranial tension secondary to obstructive 
hydrocephalus. The second most common symptom include cranial nerve palsies 
including third, fourth, sixth, seventh and lower cranial nerve palsies. 
 
 
 
 
c) Distribution of various imaging features among the histology of posterior 
fossa tumors in the study population. 
The various MR imaging characteristics of the posterior fossa tumors were 
studied. They were grouped into: 
1. Tumor characteristic 
a) Cystic 
b) Solid 
c) mixed 
 
2.  Tumor location 
a) Midline 
b) Midline with lateral extension 
 
TABLE – 4 
 HISTOLOGY 
 
PILOCYTIC 
ASTROCYTOMA 
EPENDYMOMA MEDULLOBLASTOMA 
DIFFUSE 
ASTROCYTOMA 
OTHERS 
HPE 
NOT 
DONE 
TOTAL 
CYSTIC 10 0 0 0 0 0 10 
SOLID 4 6 12 2 2 5 31 
MIXED 3 6 1 0 1 0 11 
TOTAL 17 12 13 2 3 5 52 
OTHERS – Haemangioblastoma, germinoma, chloroma 
HPE NOT DONE – Histology was not done because these tumors are intrinsic   
     brain stem tumors 
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 OTHERS – Haemangioblastoma, germinoma, chloroma 
          HPE NOT DONE – Histology was not done because these tumors are 
    intrinsic brain stem tumors 
 
From the above table - 4 and chart - 7, it is clear that pilocytic astrocytoma more 
commonly appears as cystic mass in the MRI where as medulloblastoma and 
intrinsic brain stem tumors almost always present as solid lesions. Ependymoma 
present as solid as well as mixed lesions in equal proportions. 
 
 
 
 
 
TABLE - 5 
 HISTOLOGY 
 
PILOCYTIC 
ASTROCYTOMA 
EPENDYMOMA MEDULLOBLASTOMA 
DIFFUSE 
ASTROCYTOMA 
OTHERS 
HPE 
NOT 
DONE 
TOTAL 
MIDLINE 10 8 12 2 1 5 38 
MIDLINE WITH 
LATERAL 
EXTENSION 
7 4 1 0 2 0 14 
TOTAL 17 12 13 2 3 5 52 
OTHERS – Haemangioblastoma, germinoma, chloroma 
HPE NOT DONE – Histology was not done because these tumors are intrinsic    
                                 brain stem tumors 
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        OTHERS – Haemangioblastoma, germinoma, chloroma 
        HPE NOT DONE – Histology was not done because these tumors are  
                                         intrinsic brain stem tumors 
  
  From the above table - 5 and chart - 8, more than 60 % of posterior fossa 
tumors occur in the midline without any lateral extension. Of all posterior fossa 
tumors, medulloblastoma and intrinsic brain stem tumors almost exclusively occur 
in the midline. Though pilocytic astrocytoma and ependymoma more commonly 
occur in the midline, they have higher probability of lateral cerebellar hemispheric 
extension than other posterior fossa tumors. 
 
 
d) Distribution of obstructive hydrocephalus in the study population 
CHART- 9 
        
 
 CHART – 10 
 
 
 
From the above charts - 9 and 10, it is clear that among the total 52 patients, 43 
(82.7%) had obstructive hydrocephalus. Among those 43 patients, 28 had pre-
operative shunting and 7 had intra-operative shunt and 2 patients had intra-
operative EVD. 6 patients with obstructive hydrocephalus were not treated with 
any form of pre-operative or intra-operative CSF diversion procedure. 
 
 
 
e) The possibility of extent of tumor resection among the histology of 
posterior fossa tumors in the study population. 
Except children with diffuse intrinsic brain stem lesions (5 out of 52), all the 
other children in the study group were subjected to surgical resection. The 
extent of resection varied among the different types of tumors due to several 
pre-operative and intra-operative factors like pre-operative general condition of 
the children, intra-operative torrential bleeding, intra-operative bradycardia, 
presence or absence of tumor-brain tissue plane and tumor adherence to brain 
stem, cranial nerves and important vessels.   
TABLE - 6 
 HISTOLOGY 
 PILOCYTIC 
ASTROCYTOMA 
EPENDYMOMA MEDULLOBLASTOMA 
DIFFUSE 
ASTROCYTOMA 
OTHERS 
HPE 
NOT 
DONE 
TOTAL 
NOT 
OPERATED 
0 0 0 0 0 5 5 
PARTIAL 
EXCISION 
5 4 1 2 0 0 12 
SUBTOTAL 
EXCISION 
1 2 3 0 1 0 7 
NEARTOTAL 
EXCISION 
4 6 5 0 1 0 16 
TOTAL 
EXCISION 
7 0 4 0 1 0 12 
TOTAL 
PATIENTS  
17 12 13 2 3 5 52 
 OTHERS – Haemangioblastoma, germinoma, chloroma 
 HPE NOT DONE – Histology was not done because these tumors are intrinsic  
                        brain stem tumors 
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OTHERS – Haemangioblastoma, germinoma, chloroma 
 HPE NOT DONE – Histology was not done because these tumors are intrinsic  
                        brain stem tumors 
 
 From the above table 6 and chart 11, the maximum extent of tumor resection 
was done for 28 patients (16 – near total; 12 –total excision). The intrinsic brain 
stem lesions with diffuse involvement of brain stem were not operated. The 
maximal extent of resection was done for medulloblastoma and pilocytic 
astrocytoma. When less than 50% of tumor removal was done, it was considered as 
biopsy or partial excision. When most of the tumor capsule was left unremoved, it 
was considered as subtotal excision. When the tumor capsule attached to the vital 
structures like brain stem and cranial nerves alone was left untouched and 
remaining tumor capsule excised, it was considered as near total excision. When 
the tumor was excised along with its capsule completely, it was considered as total 
excision. 
f) Frequency of various outcome among the study population 
The outcome of the study population (including operated as well as non-
operated cases) was analyzed. 
TABLE- 7 
 TOTAL (n = 52) 
 FREQUENCY PERCENTAGE 
CSF LEAK 11 21.20% 
LOWER CRANIAL  
NERVE PALSY 
19 36.50% 
PSEUDOMENINGOCELE 10 19.20% 
ASPIRATION 18 34.60% 
POST OPERATIVE 
HYDROCEPHALUS 
2 3.84% 
RECURRENCE 6 11.50% 
MORTALITY 20 38.50% 
CHART- 12       
 
From the above table - 7 and chart - 12, mortality is the most common outcome 
followed by aspiration pneumonitis and lower cranial nerve palsy. Being the most 
common outcome in this study, mortality is analyzed in more detail using 
statistical data and chi- square tests. 
 
I. Analyzing the age of presentation as a predictive factor in predicting the 
outcome 
TABLE- 8 
  DEATH   
P VALUE PRESENT ABSENT TOTAL 
AGE GROUP 
6 MONTHS TO 4 
YEARS 
9 12 21 
 
0.855 
5 TO 8 YEARS 8 14 22 
9 TO 12 YEARS 3 6 9 
 Total 20 32 52 
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When the age of presentation among different subgroups of age were 
analyzed as a predictor of outcome using chi square test, it was found to be 
statistically not significant (p = 0.855).  
 
II. Analyzing the presence of increase ICP features (headache and 
vomiting) as a predictive factor in predicting the outcome 
TABLE- 9 
  DEATH  
P VALUE PRESENT ABSENT TOTAL 
HEADACHE 
PRESENT 6 19 25  
0.39 ABSENT 14 13 27 
 TOTAL 20 32 52 
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TABLE- 10 
  DEATH  
P VALUE 
 PRESENT ABSENT TOTAL 
VOMITING 
PRESENT 13 25 38 
0.299 ABSENT 7 7 14 
 TOTAL 20 32 52 
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When the presence of increased ICP features (headache and vomiting) was 
analyzed as a predictor of outcome using chi square test, it was found to be 
statistically not significant (Headache p value = 0.39; Vomiting p value = 0.29). 
When the presence of increased ICP features secondary to obstructive 
hydrocephalus was detected pre-operatively, emergency CSF diversion procedures 
were done. This may be the reason why the presence of increased ICP features was 
not correlating significantly with post-operative mortality. 
  
III. Analyzing tumor characteristic (cystic or solid or mixed) as a predictive 
factor in predicting the outcome 
 
TABLE- 11 
  DEATH  
P VALUE 
  PRESENT ABSENT TOTAL 
IMAGING FEATURES 
CYSTIC 1 9 10 
0.094 
SOLID 15 16 31 
MIXED 4 7 11 
 TOTAL 20 32 52 
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 When different imaging characteristics of tumor were analyzed as a 
predictor of outcome using chi square test, it was found to be statistically not 
significant (p= 0.094). 
IV. Analyzing tumor location ( midline or midline with lateral extension) as 
a predictive factor in predicting the outcome 
TABLE- 12 
  DEATH  
TOTAL 
 
P VALUE PRESENT ABSENT 
TUMOR 
LOCATION 
MIDLINE 18 20 38  
0.30 MIDLINE WITH LATERAL 
EXTENSION 
2 12 14 
TOTAL 20 32 32 
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When the location of tumor was analyzed as predictor of outcome using chi square 
test, it was found to be statistically not significant (p=0.30). 
 
V. Analyzing the CSF diversion procedure before posterior fossa surgery 
as a predictive factor in predicting the outcome 
TABLE - 13 
  
DEATH 
    TOTAL P VALUE 
     PRESENT     ABSENT 
CSF 
DIVERSION 
PROCEDURE 
DONE 11 26 37 
0.078 NOT 
DONE 
4 2 6 
TOTAL  15 28 43 
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In the presence of obstructive hydrocephalus, pre-operative/ intra-operative CSF 
diversion procedure was analyzed as a predictor of outcome. It was found to be 
statistically just short of significant (p=0.078) 
 
 
VI. Analyzing the extent of resection as a predictive factor in predicting the 
outcome 
TABLE - 13 
  DEATH  
P VALUE 
 PRESENT ABSENT TOTAL 
EXTENT OE RESECTION 
NOT OPERATED 5 0 5 
0.020 
PARTIAL 6 6 12 
SUBTOTAL 2 5 7 
NEAR TOTAL 5 11 16 
TOTAL 2 10 12 
 TOTAL 20 32 52 
 
 
 
 
CHART -19 
 
When the extent of tumor resection was analyzed as a predictor of outcome using 
chi square test, it was found to be statistically significant (p=0.020). When the 
extent of resection was maximal (total or near total excision), the frequency of 
mortality was low.  
VII. Analyzing brain stem involvement (direct brain stem involvement or 
extension into the brain stem) as a predictive factor in predicting the 
outcome 
 
TABLE- 14 
  DEATH TOTAL P VALUE 
PRESENT ABSENT 
 
BRAIN STEM 
INVOLVEMENT 
ABSENT 8 27 35  
 
0.001 
DIRECT 
INVOLVEMENT 
10 2 12 
EXTENSION INTO 
THE BRAIN STEM 
2 3 5 
TOTAL 20 20 52 
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 When the tumor involvement to the brain stem was analyzed as a predictor 
of outcome using chi square test, it was found to be statistically significant 
(p=0.001). When the tumor involves brain stem (either directly arising from 
the brain stem or brain stem invasion by the tumor which originated 
elsewhere in the posterior fossa, the probability of mortality is high. 
  
 
 
 
FIGURE – 1: CT BRAIN PLAIN SHOWING 
HYPERDENSE LESION IN THE MIDLINE 
COMPRESSING THE FOURTH VENTRICLE WITH 
OBSTRUCTIVE HYDROCEPHALUS 
FIGURE – 2: CT BRAIN WITH CONTRAST OF 
THE SAME PATIENT SHOWING 
ENHANCEMENT OF THE LESION 
FIGURE – 3: MRI BRAIN OF THE SAME 
PATIENT SHOWING HOMOGENOUS 
ENHANCEMENT OF THE LESION 
FIGURE – 4: POST-OPERATIVE CT SCAN 
OF THE SAME PATIENT SHOWING 
COMPLETE EXCISION OF THE LESION. 
 
HISTLOGY WAS MEDULLOBLASTOMA 
   
 
 
 
 
FIGURE – 5: CT BRAIN SHOWING 
ENHANCING LESION IN THE 
MIDLINE WITH EXTENSION INTO 
LEFT SIDE DISPLACING FOURTH 
VENTRICLE TO OPPOSITE 
FIGURE – 5: MRI BRAIN OF THE 
SAME PATIENT SHOWING 
ENHANCING LESION IN THE 
MIDLINE WITH EXTENSION INTO 
LEFT SIDE DISPLACING FOURTH 
VENTRICLE TO OPPOSITE. 
FIGURE – 6: POST OP CT SCAN 
OF THE SAME PATIENT AFTER 
PARTIAL EXCISION SHOWING 
RESIDUAL LESION. 
HISTOLOGY WAS EPENDYMOMA 
  
 
 
 
 
 
 
 
 
 
FIGURE – 7: T1 WEIGHTED MRI 
SHOWING CYSTIC LESION IN THE 
CEREBELLUM 
FIGURE – 8: T2 WEIGHTED MRI 
SHOWING CYSTIC LESION IN THE 
RIGHT CEREBELLUM 
HISTOLOGY WAS PILOCYTIC 
ASTROCYTOMA 
  
 
 
 
 
 
FIGURE – 10: SPINAL SCREENING 
MRI SHOWING DROP METASTASIS 
AT C5 – C7 REGION WITH 
POSTERIOR FOSSA LESION 
 
HISTOLOGY WAS MEDULLOBLASTOMA 
FIGURE – 9: MRI BRAIN 
SHOWING DIFFUSE INTRINSIC 
BRAIN STEM LESION WITH 
ENLARGEMENT OF THE BRAIN 
STEM. 
DIRECT IRRADIATION WAS 
GIVEN. 
DISCUSSION 
DEMOGRAPTHY 
The study of Naseem Ahmed et al
2
 who reviewed 81 cases of posterior fossa 
tumors at a tertiary center in Karachi was compared with our study. He studied the 
incidence of posterior fossa tumors among three age groups of children less than 
14 years (0- 4 years, 5- 9 years, 10- 14 years). The maximum number of cases was 
observed in the second age group (5-9 years). The pediatric brain tumors in 
Karachi had a strong male predisposition (male- 58; female- 23) and a late 
presentation with a peak in the 5-9 year age group. Our study is comparable to this 
study. In our study also, the maximum number of cases (22 (42%) cases) was 
found in group 2 (5 to 8 years). This is followed by group 1 (6 months to 4 years) 
which had 21 (41%) cases. But in our study, there was slight female predisposition 
for posterior fossa tumors (female - 27 cases; male – 25 cases). 
The study of Kayama T et al
9
 in which piloytic astrocytoma commonly 
occurred in the age group 5 to 10 years with equal distribution among both sexes 
was compared with our study. In our study, pilocytic astrocytoma occurred 
commonly in the age group 5 to 8 years but these tumors were more common in 
the females (female to male ratio 1.4:1). 
 
 
MEDULLOBLASTOMA 
The review article published by Dattatraya Muzumdar and Enrique CG 
Ventureyra
12
 which stated that medulloblastoma occurs predominantly in males 
(ratio 1.4:1) and at a median age of 5 to 7 years was compared with our study. In 
our study also, medulloblastoma is more common in the age group 5 to 9 years 
with male predisposition (male female ratio is 1.6:1). 
EPENDYMOMA 
On comparing the study of Fulya Yaman Agaoglu, MD
14
 et al on 
ependymomas in which males (22) were more commonly affected than females 
(18) and the mean age was 5.5 year, our study showed ependymomas were more 
commonly seen below 4 years of age and these tumors were equally distributed 
among both sexes. 
SYMPTOMS 
The study done by Anthony. J. Raimondi et al
4
 in which he studied the 
incidence, symptomatology and management of hydrocephalus associated with 
posterior fossa tumors in 156 children and with pineal tumors in 21 children was 
compared with our study. He classified the symptoms into two groups as 
hydrocephalic symptoms and non- hydrocephalic symptoms. Of total 177 patients, 
143 patients had hydrocephalic symptoms. 123 children were subjected to CSF 
diversion procedure before tumor surgery. In our study also, the hydrocephalic 
symptoms (60.6 %) were more common than the non-hydrocephalic symptoms 
(50%). 
CSF DIVERSION PROCEDURES 
The study done by Leland Albright et al
5
 in which 86 patients with posterior 
fossa tumors with secondary hydrocephalus based on the treatment of obstructive 
hydrocephalus was compared with our study. In his study, 47 children had not been 
treated with any CSF diversion procedures. 27 patients were treated with VP shunt 
before tumor surgery and 12 patients were treated with EVD at the time of 
posterior fossa surgery. His conclusion was that the peri-operative mortality was 
less in the shunted group compared to non-shunted group was compared with our 
study. In our study, among the total 52 patients, 43 (82.7%) had obstructive 
hydrocephalus. Among those 43 patients, 28 had pre-operative shunting and 7 had 
intra-operative shunt and 2 patients had intra-operative EVD. 6 patients with 
obstructive hydrocephalus were not treated with any form of pre-operative or intra-
operative CSF diversion procedure. Only 29.7% (11 cases out of 37) of the patients 
who were subjected to any form of CSF diversion procedures ultimately died after 
posterior fossa surgery. Around 66.7% (4 cases out of 6) of the patients who were 
not subjected to any CSF diversion procedure died after posterior fossa surgery. 
This implies that any CSF diversion procedure significantly reduces the peri-
operative mortality. 
 IMAGING FEATURES 
The study done by Jeffrey E. Arle, M.D
8
 et al who obtained radiological data 
via MRI in 33 children with posterior fossa tumors was compared with our study. 
In his study, 11 imaging characteristics were noted for each patient and he 
correlated the imaging characteristics and the pathology of tumors. He was able to 
predict the tumor pathology in 87.8% of patients when other factors like age, sex 
and spectroscopy were added to the imaging characteristics. Based on his study, 
the imaging characteristics of posterior fossa tumors (solid/cystic/ mixed/ midline/ 
lateral extension) in our study were analyzed as a predictive factor of predicting 
post-operative mortality. But both the tumor appearance (solid / cystic /mixed) as 
well as tumor location on imaging was not correlating with mortality in our study 
population.  
COMPLICATIONS 
The study done by Jay Riva Cambrin. M.D. M.Sc. et al
19
 who studied the 
frequency of post resection hydrocephalus in children with posterior fossa tumors 
was compared with our study. Approximately 30% of pediatric patients with 
posterior fossa tumors exhibit hydrocephalus after tumor resection. In our study, 
only 2 (3.8%) of the cases had post-operative hydrocephalus for whom there was 
no pre-operative hydrocephalus. Both the patients were subjected to VP shunt. 
The retrospective analysis of Steinbok P et al
21
 who analyzed children with 
posterior fossa tumors treated surgically who had CSF leak and 
pseudomeningocele was compared with our study. He concluded that craniectomy 
was protective in preventing pseudomeningocele and CSF leak. In our study, 10 
patients (19.2%) had pseudomeningocele and 11 patients (21.2%) had CSF leak. 
This relatively high proportion of these complications was probably due to the fact 
that craniectomy was performed in our study population rather than craniotomy 
and replacing the bone flap.  
On comparing Luigi Ferrante, M.D et al
22
 who reported three cases of 
mutism after posterior fossa surgery, we had no patients with mutism 
postoperatively in our study. 
PROGNOSTICATING FACTORS 
Only few studies in the literature analyzed the predictors of outcome of 
posterior fossa tumors. Sarkar C et al
23
 studied the new methods of risk 
stratifications among medulloblastoma. Previously a clinical risk-stratification 
system was widely used in medulloblastoma based on age, extent of resection and 
the Chang staging system. According to his study, the most accurate factor 
predicting the outcome till date has been obtained through microarray gene 
expression profiling. But in our study, micro array gene expression profiling was 
not done. The most important factors predicting the outcome were brain stem 
involvement of the tumor (p=0.001) and extent of tumor resection (p=0.02). 
The study done by Figarella-Branger D et al
24
 who retrospectively assessed 
the prognostic factors in intracranial ependymomas in 37 children was compared 
with our study. He analyzed the prognostic relevance of patient age and sex, extent 
of tumor removal, location of the tumor (midline compared with lateral extension), 
tumor histological composition and adjuvant therapies in affecting the outcome of 
the patients. On univariate analysis of his study, total surgical resection and 
median infratentorial location were associated with a better outcome. Our study 
was comparable to this study because when the extent of resection was maximal 
(total or near total excision), the frequency of post-operative mortality was low. 
But the location of the tumor was not correlating with the better outcome in our 
study (p= 0.30). 
 CONCLUSION 
 
1. The demographic data obtained in our study like frequency of posterior fossa 
tumors among different age group and their sex predilection was almost 
comparable to other studies with few exceptions. 
2. The most common posterior fossa tumor in our study population was pilocytic 
astrocytoma (32.7%) followed by medulloblastoma (25%). 
3. The most common symptom produced by the posterior fossa tumors in our 
study population were those due to increased intracranial pressure secondary to 
obstructive hydrocephalus. 
4. Most of the posterior fossa tumors in our study population were solid tumors 
(59.6%) and present in the midline (73%).  
5. CSF diversion procedures were done in most of the patients (86%) having 
obstructive hydrocephalus rather than subjecting to the posterior fossa surgery 
directly (14%). 
6. Maximum extent of resection (67%) was more commonly done than partial 
excision/ biopsy (23%). Patients with diffuse intrinsic brain stem lesion (0.1%) 
were subjected to direct radiotherapy without surgery.  
7. The most common outcome in our study was death.  
8. The most important factors predicting the outcome of our study population were 
involvement of the brain stem by the tumor and the extent of resection. 
9. The factors like age, imaging characteristic, location of the tumor within the 
cerebellum, pre-operative hydrocephalus, CSF diversion procedures were not 
significantly correlated with the outcome of the patients in our study 
population. 
 
LIMITATIONS OF THE STUDY 
 
1. Other imaging features like presence of T2 hypointensity, contrast 
enhancement, necrosis, calcification and distortion/displacement of the fourth 
ventricle were not taken for the analysis. 
2. Intraoperative factors like uncontrollable bleeding, bradycardia and hypotension 
were not taken for the analysis. 
3. The duration of the study period was only 2 years which was not significant for 
following up the patients. 
4. Since it was decided to analyze the study with criteria like demographic data, 
symptoms, imaging features, CSF diversion procedures and extent of resection, 
it was decided to leave the details of adjuvant therapy (radiotherapy and 
chemotherapy). 
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MADRAS MEDICAL COLLEGE 
RAJIV GANDHI GOVT GENERAL HOSPITAL, CHENNAI 
PROFORMA 
ANALYTICAL STUDY OF POSTERIOR FOSSA TUMORS IN 
PEDIATRIC POPULATION 
S.No: 
NAME:      AGE:    SEX:   
IP NO:                     MIN NO:   
DATE OF ADMISSION:   DATE OF DISCHARGE: 
PRESENTING COMPLAINTS: 
HEADACHE     VOMITING        VISUAL BLURRING 
REFUSAL OF FEEDS       SWAYING   OBTUNDATION     
  FAILURE TO THRIVE                        ASPIRATION  
 
                        
CT BRAIN: 
SOLID 
CYSTIC 
MIXED  
MIDLINE    
MIDLINE WITH LATERAL EXTENSION 
OBSTRUCTIVE HYDROCEPHALUS    
 
MRI BRAIN 
SOLID 
CYSTIC 
MIXED  
MIDLINE    
MIDLINE WITH LATERAL EXTENSION 
OBSTRUCTIVE HYDROCEPHALUS  
  
SURGERY 
 PRE OP VP SHUNT: 
 INTRA OP VP SHUNT/ EVD: 
 POST OP SHUNT/ EVD 
 EXTENT OF RESECTION:  BIOPSY/PARTIAL 
      SUBTOTAL 
      NEAR TOTAL 
          TOTAL 
 
HISTOLOGY:  
     MEDULLOBLASTOMA 
        EPENDYMOMA 
        PILOCYTIC ASTROCYTOMA 
       DIFFUSE ASTROCYTOMA 
       OTHERS 
 
 
POST OP: 
 HYDROCEPHALUS/ IVH 
 MUTISM 
 MENINGITIS 
 PSEUDOMENINGOCELE 
 LOCAL WOUND INFECTION 
 LOWER CRANIAL NERVE PALSY 
          DEATH 
 
 
 INFORMATION SHEET 
We are conducting “ANALYTICAL STUDY OF POSTERIOR FOSSA 
TUMORS IN PEDIATRIC POPULATION” 
Among patients attending Rajiv Gandhi Government General Hospital, Chennai and 
for that your specimen may be valuable to us. 
 
 
 The purpose of this study is to analyze the pediatric patients with posterior 
fossa tumors 
 We are selecting certain cases and if your radiological image is found eligible, 
we may be using your specimen to perform extra tests and special studies 
which in any way do not affect your final report or management. 
 The privacy of the patients in the research will be maintained throughout the 
study. In the event of any publication or presentation resulting from the 
research, no personally identifiable information will be shared. 
 Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not result 
in any loss of benefits to which you are otherwise entitled. 
 The results of the special study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in the 
management or treatment. 
 
 
 
Signature of investigator                                             Signature of participant 
 
Date:  
        Signature of Parent/Guardian 
  
INFORMED CONSENT FORM 
 
TITLE OF THE STUDY: ANALYTICAL STUDY OF POSTERIOR FOSSA 
TUMORS IN PEDIATRIC POPULATION 
 
Name of the Participant: Dr.Nithyanand.R 
Name of the Principal (Co-Investigator): Prof.K.Maheshwar M.Ch., 
Name of the Institution: Institute of Neurology, Madras Medical College and Rajiv 
Gandhi Govt.  General Hospital, Chennai 
Name and address of the sponsor / agency(ies) (if any): None. 
 
Documentation of the informed consent 
I _____________________________ have read the information in this form (or it 
has been read to me). I was free to ask any questions and they have been answered. I 
am over 18 years of age and, exercising my free power of choice, hereby give my 
consent to be included as a participant in “ANALYTICAL STUDY OF 
POSTERIOR FOSSA TUMORS IN PEDIATRIC POPULATION” 
1. I have read and understood this consent form and the information provided to me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the investigator. 
5. I have been informed the investigator of all the treatments I am taking or have 
taken in the past ________ months including any native (alternative) treatment. 
6. I have been advised about the risks associated with my participation in this study.* 
7. I agree to cooperate with the investigator and I will inform him/her immediately if 
I suffer unusual symptoms. * 
8. I have not participated in any research study within the past ________month(s). * 
9. I have not donated blood within the past _______ months—Add if the study 
involves extensive blood sampling. * 
10. I am aware of the fact that I can opt out of the study at any time without having to 
give any reason and this will not affect my future treatment in this hospital. * 
11. I am also aware that the investigator may terminate my participation in the study 
at any time, for any reason, without my consent. * 
12. I hereby give permission to the investigators to release the information obtained 
from me as result of participation in this study to the sponsors, regulatory authorities, 
Govt. agencies, and IEC. I understand that they are publicly presented.* 
13. I have understand that my identity will be kept confidential if my data are publicly 
presented* 
14. I have had my questions answered to my satisfaction*. 
15. I have decided to be in the research study*. 
 
I am aware that if I have any question during this study, I should contact the 
investigator. By signing this consent form I attest that the information given in this 
document has been clearly explained to me and understood by me, I will be given a 
copy of this consent document. 
  * For Children being enrolled in research: 
Whether child’s assent was asked: Yes / No (Tick one) 
[If the answer to be above question is yes, write the following phrase: 
You agree with the manner in which assent was asked for from your child and given 
by your child. You agree to have your child take part in this study]. 
[If answer to be above question No, give reason (s) 
:___________________________________. 
Although your child did not or could not give his or her assent, you agree to your 
child’s participation in this study. 
Name and Signature of / thumb impression of the participant’s parent(s) (or legal 
representative) 
Name _________________________ Signature_________________ 
Date________________ 
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Y – YES 
N – NO 
P – PRESENT 
A – ABSENT 
P
1 – DIRECT BRAIN STEM INVOLVEMENT 
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